The fruit of a collaboration between industry and research
The development of Neolys Diagnostics tests is the result of a meeting between industry and radiobiology researchers from Lyon (INSERM unit).
A reliable technology
First of all, our team has developed a reliable technology, based on the implementation of predictive tests, allowing the personalization of radiotherapy treatments.
We are responding to a need: to predict the radiosensitivity reactions after radiotherapy for each patient, taking into account individual specificities.
We promote fundamental values, characteristic of our commitment and our work: the respect of biomedical ethics, a will to improve patients’ care and quality of life.
These values are reflected in our actions:
Our team is mainly composed of professional biology researchers, specialized in radiobiology.
A unique know-how
All our team members share a deep knowledge of individual radiosensitivity.
PhD in radiobiology, Sandrine is also an industrial transfer and medical devices specialist. She supervises the R&D department of the company.
PhD in radiobiology, Elise supervises the company’s research and development unit.
Mirlande takes part in R&D experiments and is specialized in performing radiosensitivity tests.
Phd in science specialising in chemistry and biology and a master's degree in innovation management. Patrick is in charge of business development.
